Development of c-kit-expressing small-cell lung cancer in a chronic myeloid leukemia patient during imatinib treatment

被引：6

作者：

Gambacorti-Passerini, C

Piazza, R

Tornaghi, L

Pilotti, S

Pogliani, E

机构：

[1] Univ Milano Bicocca, NCI, I-20133 Milan, Italy

[2] McGill Univ, Montreal, PQ, Canada

[3] Natl Canc Inst Milano, Monza, Italy

[4] Osped San Gerardo, Monza, Italy

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2004年 / 96卷 / 22期

关键词：

D O I：

10.1093/jnci/djh330

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1723 / 1724

页数：2

相关论文

共 7 条

[1] Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, BJ
Tamura, S
Buchdunger, E
Ohno, S
Segal, GM
Fanning, S
Zimmermann, J
Lydon, NB
[J]. NATURE MEDICINE, 1996, 2 (05) : 561 - 566
[2] Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias
Gambacorti-Passerini, CB
Gunby, RH
Piazza, R
Galietta, A
Rostagno, R
Scapozza, L
[J]. LANCET ONCOLOGY, 2003, 4 (02) : 75 - 85
[3] Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
Heinrich, MC
Corless, CL
Demetri, GD
Blanke, CD
von Mehren, M
Joensuu, H
McGreevey, LS
Chen, CJ
Van den Abbeele, AD
Druker, BJ
Kiese, B
Eisenberg, B
Roberts, PJ
Singer, S
Fletcher, CDM
Silberman, S
Dimitrijevic, S
Fletcher, JA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4342 - 4349
[4] Johnson BE, 2003, CLIN CANCER RES, V9, P5880
[5] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
Kantarjian, H
Sawyers, C
Hochhaus, A
Guilhot, F
Schiffer, C
Gambacorti-Passerini, C
Niederwieser, D
Resta, D
Capdeville, R
Zoellner, U
Talpaz, M
Druker, B
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) : 645 - 652
[6] Krystal GW, 1996, CANCER RES, V56, P370
[7] Effect of imatinib on haematopoietic recovery following idarubicin exposure
Ruchatz, H
Puttini, M
Cleris, L
Pilotti, S
Gambacorti-Passerini, C
Formelli, F
[J]. LEUKEMIA, 2003, 17 (02) : 298 - 304